Executive Board enlarged

New members of the Executive Board of the ZEISS Group Effective 1 January 2018, Dr. Karl Lamprecht for the Semiconductor Manufacturing Technology segment and Dr. Jochen Peter for the Research & Quality Technology segment have been appointed to the Executive Board of the ZEISS Group Thomas Spitzenpfeil, Member of the Executive Board, to pursue new... Read more

New field emission scanning electron microscope ZEISS GeminiSEM 450 introduced

Addressing the highest demands in imaging and analytics from any sample JENA/Germany, 2017-12-04. ZEISS introduces its new field emission scanning electron microscope (FE-SEM) ZEISS GeminiSEM 450. The instrument combines ultrahigh resolution imaging with the capability to perform advanced analytics while maintaining flexibility and ease-of-use. With ZEISS GeminiSEM 450, users benefit from high resolution, surface sensitive... Read more

Shimadzu's New TD-30 Series of Thermal Desorption Systems for Gas Chromatographs and GCMS Systems Provides Accurate Analysis of Volatile Compounds

A thermal desorption system is a pretreatment unit in which a tube that concentrates volatile components is heated, and the volatile components from the tube are loaded into an analytical instrument with high sensitivity. It has been used for the analysis of toxic substances in the atmosphere and substances responsible for sick house syndrome included... Read more

Consolidated Financial Statements for the Second Quarter Ended September 30, 2017

2Q Results, September 30, 2017(PDF)    This article is translated from press release in Japanese for your convenience. Forward-Looking StatementsStatements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based... Read more

BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines

FRANKLIN LAKES, N.J., Nov. 16, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s announcement by Merit Medical Systems, Inc. that it has signed a definitive agreement to acquire BD’s soft tissue core needle biopsy product line and C. R. Bard’s (NYSE:... Read more

New 2D Superresolution mode for ZEISS Airyscan delivers 120 nanometer lateral resolution

Improved optical sectioning delivers higher resolution without the need to acquire a z-stack JENA/Germany, 2017-11-15. At Neuroscience 2017, a new imaging mode for the ZEISS LSM 8 family with Airyscan has been introduced. Their unique 32-channel GaAsP array detector captures more spatial information than traditional confocal microscopes. The new 2D Superresolution mode now uses this... Read more

QIAGEN’s GeneReader NGS System delivers accuracy and ease of use for clinical research in oncology

Hilden, Germany, and Germantown, Maryland, November 14, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete Sample to Insight solution for next-generation sequencing. The studies are being presented this week at the... Read more

Nikon Instruments Releases New Microscope Objective for Whole Brain Imaging at Neuroscience 2017

MELVILLE, N.Y., Nov. 13, 2017 (GLOBE NEWSWIRE) — Nikon Instruments Inc., an industry leader in advanced optical instruments, is debuting the CFI90 20XC Glyc, a cutting-edge microscope objective capable of deep imaging of whole, cleared tissues, at the Society for Neuroscience’s annual Neuroscience 2017 meeting in Washington, D.C. this week. Designed to support cutting-edge neurobiology... Read more